ACM

Altium Capital Management Portfolio holdings

AUM $34.4M
1-Year Return 2.5%
This Quarter Return
-0.07%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
10 Year Return
AUM
$375M
AUM Growth
-$56.3M
Cap. Flow
-$44.2M
Cap. Flow %
-11.78%
Top 10 Hldgs %
22.52%
Holding
176
New
38
Increased
28
Reduced
15
Closed
52

Sector Composition

1 Healthcare 83.78%
2 Financials 5.42%
3 Technology 2.08%
4 Industrials 1.49%
5 Communication Services 1.31%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SRXH
126
SRX Health Solutions, Inc.
SRXH
$12.4M
-614
Closed -$86K
COCP icon
127
Cocrystal Pharma
COCP
$15.2M
-64,667
Closed -$970K
CVRX icon
128
CVRx
CVRX
$204M
-60,000
Closed -$1.68M
CYTK icon
129
Cytokinetics
CYTK
$6.34B
-84,262
Closed -$1.67M
ECOR icon
130
electroCore
ECOR
$37.1M
-333,667
Closed -$5.95M
EPIX icon
131
ESSA Pharma
EPIX
$11M
-213,528
Closed -$6.1M
FULC icon
132
Fulcrum Therapeutics
FULC
$414M
-213,533
Closed -$2.24M
GKOS icon
133
Glaukos
GKOS
$5.39B
-40,400
Closed -$3.43M
GRI icon
134
GRI Bio
GRI
$4.18M
-3
Closed -$878K
IKT icon
135
Inhibikase Therapeutics
IKT
$124M
-18,292
Closed -$307K
IMCC
136
IM Cannabis
IMCC
$10.3M
-5,364
Closed -$1.71M
IMVT icon
137
Immunovant
IMVT
$2.99B
-335,041
Closed -$3.54M
INMB icon
138
INmune Bio
INMB
$51.8M
-52,257
Closed -$918K
IRTC icon
139
iRhythm Technologies
IRTC
$5.82B
-15,206
Closed -$1.01M
KRYS icon
140
Krystal Biotech
KRYS
$4.35B
0
MCRB icon
141
Seres Therapeutics
MCRB
$169M
-5,231
Closed -$2.5M
OPAD icon
142
Offerpad Solutions
OPAD
$156M
-6,667
Closed -$993K
RYTM icon
143
Rhythm Pharmaceuticals
RYTM
$6.78B
-104,840
Closed -$2.05M
SNCR icon
144
Synchronoss Technologies
SNCR
$61.8M
-3,611
Closed -$117K
STIM icon
145
Neuronetics
STIM
$214M
-184,554
Closed -$2.96M
TARS icon
146
Tarsus Pharmaceuticals
TARS
$2.43B
-70,573
Closed -$2.05M
TBPH icon
147
Theravance Biopharma
TBPH
$703M
-220,000
Closed -$3.19M
TKNO icon
148
Alpha Teknova
TKNO
$233M
-25,000
Closed -$593K
VANI icon
149
Vivani Medical
VANI
$76.4M
-124,622
Closed -$1.85M
TVRD
150
Tvardi Therapeutics, Inc. Common Stock
TVRD
$292M
-4,167
Closed -$2.14M